Meng Han
Qinhuangdao, 066000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A novel prognostic signature based on epithelial-mesenchymal transition-associated genes for the prognosis and immune status in breast cancer.
Journal: American journal of translational research
Published: September 24, 2025
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: February 24, 2025
PER1 Serves as a Tumor Suppressor in Breast Cancer by Regulating MEK5/ERK5 Signaling Pathway.
Journal: International journal of general medicine
Published: December 23, 2024
Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer.
Journal: Oncology research
Published: November 29, 2024
USP53 Affects the Proliferation and Apoptosis of Breast Cancer Cells by Regulating the Ubiquitination Level of ZMYND11.
Journal: Biological procedures online
Published: May 20, 2024
A photoelectrochemical aptasensor based on double Z-scheme α-Fe2O3/MoS2/Bi2S3 ternary heterojunction for sensitive detection of circulating tumor cells.
Journal: Frontiers in bioengineering and biotechnology
Published: January 18, 2024
An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic Target.
Journal: Current protein & peptide science
Published: December 16, 2023
Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer.
Journal: World journal of clinical cases
Published: December 01, 2023
SORBS1 inhibits epithelial to mesenchymal transition (EMT) of breast cancer cells by regulating PI3K/AKT signaling and macrophage phenotypic polarization.
Journal: Aging
Published: September 11, 2023
Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China.
Journal: Frontiers in genetics
Published: August 16, 2023
PER3 plays anticancer roles in the oncogenesis and progression of breast cancer via regulating MEK/ERK signaling pathway.
Journal: Journal of the Chinese Medical Association : JCMA
Published: October 24, 2022
The value of hsa_circ_0058514 in plasma extracellular vesicles for breast cancer.
Journal: Frontiers in oncology
Published: July 15, 2022
Last Updated: 09/26/2026